Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

TSHATSHA
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in TAYSHA GENE THERAPIES INC

GOLDMAN SACHS GROUP INC holds 22.7M shares of TSHA (TAYSHA GENE THERAPIES INC), worth $154.7M as of 2026-Q2. The position was increased (+1.5% shares). TSHA represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$154.7M

Current Shares

22.7M

Total Value Change

+$153M

Total Shares Change

+21.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
22.7M
+1.5%
$154.7M0.0%$6.81
31
2026-Q1
Increased
22.4M
+63.4%
$100M0.0%$4.53
44
2025-Q4
Increased
13.7M
+2.3%
$75.3M0.0%$5.66
30
2025-Q3
Increased
13.4M
+6.3%
$43.8M0.0%$3.16
31
2025-Q2
Increased
12.6M
+3406.3%
$29.1M0.0%$2.38
46
2025-Q1
Decreased
359,007
-62.9%
$499,0190.0%$1.93
0
2024-Q4
New
967,144
-
$1.7M0.0%$1.73
36

Other major holders of TSHA: Avoro Capital Advisors LLC, RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used